; (2) in subsections (a), (c), and (d)— (A) by striking approved or cleared each place it appears and inserting approved, cleared, or otherwise legally marketed ; and (B) by striking opioid each place it appears; (3) in subsection (f)— (A) by striking approved or cleared each place it appears and inserting approved, cleared, or otherwise legally marketed ; (B) in paragraph (1), by striking opioid ; (C) in paragraph (2)— (i) by striking opioid and heroin and inserting opioid, heroin, and other drug ; and (ii) by striking opioid overdose and inserting overdose ; and (D) in paragraph (3), by striking opioid and heroin ; and (4) in subsection (h), by striking $36,000,000 for each of fiscal years 2019 through 2023 and inserting $56,000,000 for each of fiscal years 2024 through 2028 . 102. Surveillance and education regarding infections associated with illicit drug use and other risk factors Section 317N(d) of the Public Health Service Act ( 42 U.S.C. 247b–15(d) ) is amended by striking 2019 through 2023 and inserting 2024 through 2028 . 103. Preventing overdoses of controlled substances Section 392A of the Public Health Service Act ( 42 U.S.C. 280b–1 ) is amended— (1) in subsection (a)— (A) in paragraph (2)— (i) in subparagraph (C), by inserting and associated risks before the period at the end; and (ii) in subparagraph (D), by striking opioids and inserting substances causing overdose ; (B) in paragraph (3)(A)— (i) by inserting identify substances causing overdose and after rapidly ; and (ii) by striking abuse, and overdoses and inserting overdoses, and associated risk factors ; (2) in subsection (b)(2)— (A) in subparagraph (B), by inserting , and associated risk factors, after such overdoses ; (B) in subparagraph (C), by striking coding and inserting monitoring and identifying ; (C) in subparagraph (E)— (i) by inserting a comma after public health laboratories ; and (ii) by inserting and other emerging substances related after analogues